Authors: Chen, HX Marshall, JL Ness, E Martin, RR Dvorchik, B Rizvi, N Marquis, J McKinlay, M Dahut, W Hawkins, MJ

Citation: Hx. Chen et al., A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors, CLIN CANC R, 6(4), 2000, pp. 1259-1266

Authors: Wu-Pong, S Livesay, V Dvorchik, B Barr, WH

Citation: S. Wu-pong et al., Oligonucleotide transport in rat and human intestine ussing chamber models, BIOPHARM DR, 20(9), 1999, pp. 411-416

Authors: Sereni, D Tubiana, R Lascoux, C Katlama, C Taulera, O Bourque, A Cohen, A Dvorchik, B Martin, RR Tournerie, C Gouyette, A Schechter, PJ

Citation: D. Sereni et al., Pharmacokinetics and tolerability of intravenous Trecovirsen (GEM (R) 91),an antisense phosphorothioate oligonucleotide, in HIV-positive subjects, J CLIN PHAR, 39(1), 1999, pp. 47-54